Company Info
Satellos Bioscience Inc. is a biotechnology company focused on developing regenerative therapies for muscle disorders. Based in Canada, Satellos aims to harness the body's natural repair mechanisms, particularly through its proprietary MyoReGenX™ platform. This technology targets muscle stem cells to promote repair and regeneration, with an emphasis on treating conditions like Duchenne Muscular Dystrophy (DMD). By advancing innovative treatments, Satellos seeks to offer new hope for patients with muscle-wasting diseases, potentially transforming the therapeutic landscape for degenerative muscular conditions.
Company Website